Postmenopausal breast cancer
Conditions
Interventions
Divide into a study group and a control group based on whether major cardiovascular outcomes have occurred:NA
Sponsors
The First Affiliated Hospital of Dalian Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: ( 1 ) Breast cancer patients diagnosed for the first time in the First Affiliated Hospital of Dalian Medical University from January 2011 to December 2018 and in Qilu Hospital of Shandong University ( Qingdao ) from January 2014 to December 2018. ( 2 ) Postmenopausal breast cancer patients. ( 3 ) Endocrine therapy, including or not including any chemoradiotherapy and targeted therapy, is included in the treatment plan developed by clinicians for patients according to the National Comprehensive Cancer Network ( NCCN ). ( 4 ) Case information is completely stored in the electronic medical record research database of the corresponding center and collected in a desensitization manner.
Exclusion criteria
Exclusion criteria: ( 1 ) The tumor stage was IV or no detailed evaluation was performed to determine the clinical stage of the tumor. ( 2 ) The diagnosis of breast cancer with other parts of the solid tumors or hematological tumors. ( 3 ) Endocrine therapy drugs have been used before the diagnosis of breast cancer. ( 4 ) Loss of follow-up. ( 5 ) Serious incomplete / missing data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood pressure;serum glucose;high density lipoprotein-cholesterol;triglyceride;body mass index;heart failure;acute coronary syndrome;stroke;cardiac death;endocrine therapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| low density lipoprotein-cholesterol;alanine aminotransferase;radiotherapy;chemotherapy;surgery; | — |
Countries
China
Contacts
Public ContactYunlong Xia
The First Affiliated Hospital of Dalian Medical University
Outcome results
None listed